NYSE ARCA | ETF
The fund, under normal circumstances, invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index, that, in combination, provide 3X daily leveraged exposure to the index, consistent with the fund's investment objective.
The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards (GICS).
The fund is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRNA | Moderna Inc | Healthcare | Biotechnology | 1.67% |
| KRTX | Karuna Therapeutics Inc | Healthcare | Biotechnology | 1.41% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 1.29% |
| ROIV | Roivant Sciences Ltd | Healthcare | Biotechnology | 1.26% |
| ACLX | Arcellx Inc | Healthcare | Biotechnology | 1.23% |
| PCVX | Vaxcyte Inc | Healthcare | Biotechnology | 1.15% |
| RVMD | Revolution Medicines Inc | Healthcare | Biotechnology | 1.14% |
| CGON | CG Oncology, Inc. Common stock | Healthcare | Biotechnology | 1.13% |
| FOLD | Amicus Therapeutics Inc | Healthcare | Biotechnology | 1.10% |
| MIRM | Mirum Pharmaceuticals Inc | Healthcare | Biotechnology | 1.09% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 1.07% |
| PRAX | Praxis Precision Medicines Inc | Healthcare | Biotechnology | 1.04% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 1.03% |
| CELC | Celcuity LLC | Healthcare | Biotechnology | 1.01% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 1.00% |
| KRYS | Krystal Biotech Inc | Healthcare | Biotechnology | 0.96% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 0.96% |
| ALPN | Alpine Immune Sciences Inc | Healthcare | Biotechnology | 0.94% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 0.94% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 0.94% |